vs
Pennant Group, Inc.（PNTG）与Rocket Lab Corp（RKLB）财务数据对比。点击上方公司名可切换其他公司
Pennant Group, Inc.的季度营收约是Rocket Lab Corp的1.6倍（$289.3M vs $179.7M），Pennant Group, Inc.净利率更高（3.0% vs -29.5%，领先32.4%），Pennant Group, Inc.同比增速更快（53.2% vs 35.7%），Pennant Group, Inc.自由现金流更多（$17.4M vs $-114.2M），过去两年Rocket Lab Corp的营收复合增速更高（39.2% vs 35.8%）
Pennant Group, Inc.是一家总部位于美国的医疗服务企业，主营家庭健康护理、临终关怀、长者居住服务及专业护理服务，业务覆盖美国数十个州，核心服务对象为老年及有特殊医疗需求的弱势人群。
Rocket Lab是公开上市的航空航天制造商及发射服务提供商，旗下Electron轨道火箭主打小型卫星发射，截至2026年1月已成功完成超75次任务，是全球现役发射次数最多的小型运载火箭。公司还开发了Electron的亚轨道改型HASTE用作高超音速技术测试平台，下一代可复用中型运载火箭Neutron目前也在研发中。
PNTG vs RKLB — 直观对比
营收规模更大
PNTG
是对方的1.6倍
$179.7M
营收增速更快
PNTG
高出17.5%
35.7%
净利率更高
PNTG
高出32.4%
-29.5%
自由现金流更多
PNTG
多$131.6M
$-114.2M
两年增速更快
RKLB
近两年复合增速
35.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $289.3M | $179.7M |
| 净利润 | $8.6M | $-52.9M |
| 毛利率 | — | 38.0% |
| 营业利润率 | 6.0% | -28.4% |
| 净利率 | 3.0% | -29.5% |
| 营收同比 | 53.2% | 35.7% |
| 净利润同比 | 50.0% | -1.1% |
| 每股收益（稀释后） | $0.25 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PNTGRKLB
| Q4 25 | $289.3M | $179.7M | ||
| Q3 25 | $229.0M | $155.1M | ||
| Q2 25 | $219.5M | $144.5M | ||
| Q1 25 | $209.8M | $122.6M | ||
| Q4 24 | $188.9M | $132.4M | ||
| Q3 24 | $180.7M | $104.8M | ||
| Q2 24 | $168.7M | $106.3M | ||
| Q1 24 | $156.9M | $92.8M |
净利润PNTGRKLB
| Q4 25 | $8.6M | $-52.9M | ||
| Q3 25 | $6.1M | $-18.3M | ||
| Q2 25 | $7.1M | $-66.4M | ||
| Q1 25 | $7.8M | $-60.6M | ||
| Q4 24 | $5.8M | $-52.3M | ||
| Q3 24 | $6.2M | $-51.9M | ||
| Q2 24 | $5.7M | $-41.6M | ||
| Q1 24 | $4.9M | $-44.3M |
毛利率PNTGRKLB
| Q4 25 | — | 38.0% | ||
| Q3 25 | — | 37.0% | ||
| Q2 25 | — | 32.1% | ||
| Q1 25 | — | 28.8% | ||
| Q4 24 | — | 27.8% | ||
| Q3 24 | — | 26.7% | ||
| Q2 24 | — | 25.6% | ||
| Q1 24 | — | 26.1% |
营业利润率PNTGRKLB
| Q4 25 | 6.0% | -28.4% | ||
| Q3 25 | 4.5% | -38.0% | ||
| Q2 25 | 5.3% | -41.3% | ||
| Q1 25 | 6.0% | -48.3% | ||
| Q4 24 | 4.9% | -38.9% | ||
| Q3 24 | 6.0% | -49.5% | ||
| Q2 24 | 5.7% | -40.7% | ||
| Q1 24 | 5.4% | -46.4% |
净利率PNTGRKLB
| Q4 25 | 3.0% | -29.5% | ||
| Q3 25 | 2.7% | -11.8% | ||
| Q2 25 | 3.2% | -46.0% | ||
| Q1 25 | 3.7% | -49.5% | ||
| Q4 24 | 3.0% | -39.5% | ||
| Q3 24 | 3.4% | -49.6% | ||
| Q2 24 | 3.4% | -39.2% | ||
| Q1 24 | 3.1% | -47.7% |
每股收益（稀释后）PNTGRKLB
| Q4 25 | $0.25 | $-0.09 | ||
| Q3 25 | $0.17 | $-0.03 | ||
| Q2 25 | $0.20 | $-0.13 | ||
| Q1 25 | $0.22 | $-0.12 | ||
| Q4 24 | $0.16 | $-0.11 | ||
| Q3 24 | $0.20 | $-0.10 | ||
| Q2 24 | $0.18 | $-0.08 | ||
| Q1 24 | $0.16 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $1.0B |
| 总债务越低越好 | $168.8M | $152.4M |
| 股东权益账面价值 | $374.3M | $1.7B |
| 总资产 | $968.2M | $2.3B |
| 负债/权益比越低杠杆越低 | 0.45× | 0.09× |
8季度趋势，按日历期对齐
现金及短期投资PNTGRKLB
| Q4 25 | — | $1.0B | ||
| Q3 25 | — | $976.7M | ||
| Q2 25 | — | $688.1M | ||
| Q1 25 | — | $428.4M | ||
| Q4 24 | — | $419.0M | ||
| Q3 24 | — | $442.4M | ||
| Q2 24 | — | $496.8M | ||
| Q1 24 | — | $492.5M |
总债务PNTGRKLB
| Q4 25 | $168.8M | $152.4M | ||
| Q3 25 | $26.0M | $347.0M | ||
| Q2 25 | $37.0M | $346.5M | ||
| Q1 25 | $52.5M | $345.9M | ||
| Q4 24 | $0 | $345.4M | ||
| Q3 24 | $108.9M | $61.2M | ||
| Q2 24 | $82.2M | $64.2M | ||
| Q1 24 | $83.3M | $66.8M |
股东权益PNTGRKLB
| Q4 25 | $374.3M | $1.7B | ||
| Q3 25 | $343.0M | $1.3B | ||
| Q2 25 | $333.6M | $688.5M | ||
| Q1 25 | $323.0M | $431.3M | ||
| Q4 24 | $312.0M | $382.5M | ||
| Q3 24 | $187.3M | $419.8M | ||
| Q2 24 | $173.0M | $455.2M | ||
| Q1 24 | $164.2M | $478.9M |
总资产PNTGRKLB
| Q4 25 | $968.2M | $2.3B | ||
| Q3 25 | $753.6M | $2.2B | ||
| Q2 25 | $751.4M | $1.6B | ||
| Q1 25 | $743.6M | $1.3B | ||
| Q4 24 | $679.5M | $1.2B | ||
| Q3 24 | $646.8M | $1.2B | ||
| Q2 24 | $602.5M | $1.2B | ||
| Q1 24 | $578.2M | $1.2B |
负债/权益比PNTGRKLB
| Q4 25 | 0.45× | 0.09× | ||
| Q3 25 | 0.08× | 0.27× | ||
| Q2 25 | 0.11× | 0.50× | ||
| Q1 25 | 0.16× | 0.80× | ||
| Q4 24 | 0.00× | 0.90× | ||
| Q3 24 | 0.58× | 0.15× | ||
| Q2 24 | 0.48× | 0.14× | ||
| Q1 24 | 0.51× | 0.14× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $21.0M | $-64.5M |
| 自由现金流经营现金流 - 资本支出 | $17.4M | $-114.2M |
| 自由现金流率自由现金流/营收 | 6.0% | -63.6% |
| 资本支出强度资本支出/营收 | 1.2% | 27.6% |
| 现金转化率经营现金流/净利润 | 2.43× | — |
| 过去12个月自由现金流最近4个季度 | $36.3M | $-321.8M |
8季度趋势，按日历期对齐
经营现金流PNTGRKLB
| Q4 25 | $21.0M | $-64.5M | ||
| Q3 25 | $13.9M | $-23.5M | ||
| Q2 25 | $34.6M | $-23.2M | ||
| Q1 25 | $-21.2M | $-54.2M | ||
| Q4 24 | $20.6M | $-2.4M | ||
| Q3 24 | $7.7M | $-30.9M | ||
| Q2 24 | $10.5M | $-13.0M | ||
| Q1 24 | $545.0K | $-2.6M |
自由现金流PNTGRKLB
| Q4 25 | $17.4M | $-114.2M | ||
| Q3 25 | $10.5M | $-69.4M | ||
| Q2 25 | $31.6M | $-55.3M | ||
| Q1 25 | $-23.2M | $-82.9M | ||
| Q4 24 | $17.2M | $-23.9M | ||
| Q3 24 | $6.8M | $-41.9M | ||
| Q2 24 | $8.9M | $-28.3M | ||
| Q1 24 | $-2.6M | $-21.8M |
自由现金流率PNTGRKLB
| Q4 25 | 6.0% | -63.6% | ||
| Q3 25 | 4.6% | -44.8% | ||
| Q2 25 | 14.4% | -38.3% | ||
| Q1 25 | -11.1% | -67.6% | ||
| Q4 24 | 9.1% | -18.1% | ||
| Q3 24 | 3.8% | -40.0% | ||
| Q2 24 | 5.3% | -26.7% | ||
| Q1 24 | -1.7% | -23.5% |
资本支出强度PNTGRKLB
| Q4 25 | 1.2% | 27.6% | ||
| Q3 25 | 1.5% | 29.6% | ||
| Q2 25 | 1.4% | 22.2% | ||
| Q1 25 | 0.9% | 23.4% | ||
| Q4 24 | 1.8% | 16.3% | ||
| Q3 24 | 0.5% | 10.5% | ||
| Q2 24 | 1.0% | 14.4% | ||
| Q1 24 | 2.0% | 20.7% |
现金转化率PNTGRKLB
| Q4 25 | 2.43× | — | ||
| Q3 25 | 2.29× | — | ||
| Q2 25 | 4.89× | — | ||
| Q1 25 | -2.73× | — | ||
| Q4 24 | 3.57× | — | ||
| Q3 24 | 1.24× | — | ||
| Q2 24 | 1.84× | — | ||
| Q1 24 | 0.11× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PNTG
| Home Health Subsegment | $136.2M | 47% |
| Hospice Subsegment | $97.1M | 34% |
| Private And Other | $36.4M | 13% |
| Medicare And Medicaid | $19.6M | 7% |
| Affiliated Entity | $2.2M | 1% |
RKLB
| Products | $94.0M | 52% |
| Transferred Over Time | $87.3M | 49% |
